➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Baxter
Express Scripts
Dow
McKinsey

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR COCAINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Cocaine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000187 ↗ Ritanserin in Treatment of Cocaine Dependence - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1992-07-01 The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
NCT00000187 ↗ Ritanserin in Treatment of Cocaine Dependence - 1 Completed University of Pennsylvania Phase 2 1992-07-01 The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
NCT00000188 ↗ Selegiline in Treatment of Cocaine Dependence - 2 Completed National Institute on Drug Abuse (NIDA) Phase 2 1994-09-01 The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.
NCT00000188 ↗ Selegiline in Treatment of Cocaine Dependence - 2 Completed University of Pennsylvania Phase 2 1994-09-01 The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.
NCT00000189 ↗ Gepirone vs Placebo in Treatment of Cocaine Dependence - 3 Completed National Institute on Drug Abuse (NIDA) Phase 2 1990-01-01 The purpose of this study is to test antidepressant medication, gepirone, as a pharmacotherapy for cocaine dependent subjects.
NCT00000189 ↗ Gepirone vs Placebo in Treatment of Cocaine Dependence - 3 Completed University of Pennsylvania Phase 2 1990-01-01 The purpose of this study is to test antidepressant medication, gepirone, as a pharmacotherapy for cocaine dependent subjects.
NCT00000191 ↗ Carbamazepine Treatment for Cocaine Dependence - 5 Completed National Institute on Drug Abuse (NIDA) Phase 2 1991-01-01 The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cocaine Hydrochloride

Condition Name

Condition Name for Cocaine Hydrochloride
Intervention Trials
Cocaine-Related Disorders 141
Cocaine Dependence 134
Cocaine Use Disorder 27
Cocaine Abuse 25
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cocaine Hydrochloride
Intervention Trials
Cocaine-Related Disorders 309
Disease 70
Substance-Related Disorders 50
Opioid-Related Disorders 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cocaine Hydrochloride

Trials by Country

Trials by Country for Cocaine Hydrochloride
Location Trials
United States 494
Canada 11
Brazil 8
Germany 6
Spain 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cocaine Hydrochloride
Location Trials
Texas 67
New York 52
Connecticut 47
Pennsylvania 46
Maryland 38
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cocaine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Cocaine Hydrochloride
Clinical Trial Phase Trials
Phase 4 25
Phase 3 27
Phase 2/Phase 3 17
[disabled in preview] 318
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cocaine Hydrochloride
Clinical Trial Phase Trials
Completed 267
Recruiting 80
Unknown status 35
[disabled in preview] 70
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cocaine Hydrochloride

Sponsor Name

Sponsor Name for Cocaine Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 285
Yale University 46
New York State Psychiatric Institute 40
[disabled in preview] 87
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cocaine Hydrochloride
Sponsor Trials
Other 454
NIH 299
Industry 40
[disabled in preview] 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Merck
Harvard Business School
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.